US 9096602
Substituted pyrrolo[2,3-B]pyrazines as ATR kinase inhibitors
granted A61KA61K31/4985A61K45/06
Quick answer
US patent 9096602 (Substituted pyrrolo[2,3-B]pyrazines as ATR kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/4985, A61K45/06, A61P, A61P35/00